Evidence map›Paper›PMID 42022332›Full record

ArticleFrontiers in oncology2026

Morphology-guided attention networks for explainable skin cancer detection under clinical uncertainty.

Muhammad Zaheer Sajid, Muhammad Fareed Hamid, Zepa Yang, Mohammad Alhefdi, Shrooq Alsenan, Yunyoung Nam

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Muhammad Zaheer SajidDepartment of Electrical and Computer Engineering, George Mason University, Fairfax, VA, United States.
Muhammad Fareed HamidDepartment of Computer Software Engineering, National University of Sciences and Technology, Military College of Signals (MCS), Islamabad, Pakistan.
Zepa YangDepartment of Computer Science and Engineering, Soonchunhyang University, Asan, Republic of Korea.
Mohammad AlhefdiComputer Engineering Department, King Khalid University, Abha, Saudi Arabia.
Shrooq AlsenanInformation Systems Department, College of Computer and Information Sciences, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Yunyoung NamDepartment of Computer Science and Engineering, Soonchunhyang University, Asan, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate and reliable skin cancer detection from dermoscopic images remains challenging due to large visual variability, overlapping lesion appearances, and inherent clinical uncertainty. To address these issues, this work proposes a morphology-guided attention framework for explainable and uncertainty-aware skin lesion classification. The system integrates lesion segmentation to preserve clinically meaningful morphological structures, followed by an attention-based classification network that emphasizes diagnostically relevant regions while suppressing background artifacts. Visual attention and attribution maps are generated to provide transparent explanations aligned with established dermoscopic criteria. In addition, an uncertainty estimation module is incorporated to quantify prediction confidence and identify ambiguous or out-of-distribution cases for safe clinical triage. The proposed approach is evaluated on publicly available dermoscopic datasets and achieves classification accuracy 99.12% with a recall rate above 99% for malignant lesions, demonstrating strong sensitivity for early cancer detection. Experimental results show that morphology-guided attention improves both classification performance and interpretability compared to conventional deep learning models. Furthermore, uncertainty-aware predictions enhance model reliability by reducing overconfident errors in challenging cases. These findings indicate that the proposed framework offers a robust, explainable, and clinically relevant solution for automated skin cancer screening under real-world conditions.

Indexed as

clinical decision supportdeep learningdermoscopic image analysisexplainable artificial intelligencelesion segmentationmorphology-guided attentionskin cancer detectionuncertainty-aware learning

Identifiers

PMID42022332
PMCPMC13097149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.